Understand the source comparison
Glow Stack Not Working Reasons Fix: Component Comparison
Storage (Lyophilised) −20°C freezer, sealed desiccant bag Room temperature shelf, ambient humidity 35–80% bioactivity loss within 72 hours depending on ambient temperature Non-negotiable cold storage—temperature abuse is the single most common cause of total p
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Storage (Lyophilised)
- −20°C freezer, sealed desiccant bag
- Room temperature shelf, ambient humidity
- 35–80% bioactivity loss within 72 hours depending on ambient temperature
- Non-negotiable cold storage—temperature abuse is the single most common cause of total protocol failure
- Storage (Reconstituted)
- 2–8°C refrigerator back compartment
- Refrigerator door or countertop between uses
- Bacterial growth within 48–96 hours; protein denaturation above 10°C
- Use dedicated research fridge with thermometer verification—household fridges fluctuate too widely
- Reconstitution Medium
- Bacteriostatic water (0.9% benzyl alcohol)
- Sterile water or saline
- Sterile water: 72-hour use window; saline: precipitation with certain peptides
- Bacteriostatic water extends multi-dose stability to 28 days—always verify correct medium before mixing
- Reconstitution Volume
- Precise volumetric measurement (e.g., 2.00mL to 5mg vial = 2.5mg/mL)
- Eyeballing volume or using insulin syringe
- 25–50% concentration error compounding across all doses
- Use luer-lock syringe with 0.01mL gradations—imprecise volume creates imprecise dosing throughout the vial's lifespan
- Injection Site
- Abdomen 2 inches lateral to navel, rotated across 6 mapped sites
- Same site repeatedly or areas with low subcutaneous fat
- Lipohypertrophy/lipoatrophy reducing absorption by 20–40%
- Rotation prevents tissue changes that impair absorption—document every injection to avoid overlap
- Injection Depth
- Subcutaneous (0.5–1 inch, 45° angle, pinched skin fold)
- Intradermal (too shallow) or intramuscular (too deep)
- Intradermal: visible welt, erratic absorption; IM: altered pharmacokinetics
- Pinch skin fold before insertion—ensures needle enters subcutaneous fat layer where peptide absorption is most consistent